172 related articles for article (PubMed ID: 21041085)
1. Synthesis and biological evaluation of retinoid-chalcones as inhibitors of colon cancer cell growth.
Mizuno CS; Paul S; Suh N; Rimando AM
Bioorg Med Chem Lett; 2010 Dec; 20(24):7385-7. PubMed ID: 21041085
[TBL] [Abstract][Full Text] [Related]
2. Novel p-Functionalized Chromen-4-on-3-yl Chalcones Bearing Astonishing Boronic Acid Moiety as MDM2 Inhibitor: Synthesis, Cytotoxic Evaluation and Simulation Studies.
Bhatia RK; Singh L; Garg R; Kaur M; Yadav M; Madan J; Kancherla S; Pissurlenkar RRS; Coutinho EC
Med Chem; 2020; 16(2):212-228. PubMed ID: 31146672
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
Kumar D; Kumar NM; Akamatsu K; Kusaka E; Harada H; Ito T
Bioorg Med Chem Lett; 2010 Jul; 20(13):3916-9. PubMed ID: 20627724
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors and promoters of tubulin polymerization: synthesis and biological evaluation of chalcones and related dienones as potential anticancer agents.
Dyrager C; Wickström M; Fridén-Saxin M; Friberg A; Dahlén K; Wallén EA; Gullbo J; Grøtli M; Luthman K
Bioorg Med Chem; 2011 Apr; 19(8):2659-65. PubMed ID: 21459004
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro evaluation of novel coumarin-chalcone hybrids as potential anticancer agents.
Sashidhara KV; Kumar A; Kumar M; Sarkar J; Sinha S
Bioorg Med Chem Lett; 2010 Dec; 20(24):7205-11. PubMed ID: 21071221
[TBL] [Abstract][Full Text] [Related]
6. Natural Chalcones and Their Derivatives Target the Tumor Microenvironment in Colon Cancer.
Malla RR; Siragam S; Dadi V; Seetini B
Crit Rev Immunol; 2022; 42(6):27-39. PubMed ID: 37082949
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, anticancer activities and molecular modeling studies of novel indole retinoid derivatives.
Gurkan-Alp AS; Mumcuoglu M; Andac CA; Dayanc E; Cetin-Atalay R; Buyukbingol E
Eur J Med Chem; 2012 Dec; 58():346-54. PubMed ID: 23142674
[TBL] [Abstract][Full Text] [Related]
8. Molecular modeling based synthesis and evaluation of in vitro anticancer activity of indolyl chalcones.
Gaur R; Yadav DK; Kumar S; Darokar MP; Khan F; Bhakuni RS
Curr Top Med Chem; 2015; 15(11):1003-12. PubMed ID: 25860176
[TBL] [Abstract][Full Text] [Related]
9. Heterocyclic chalcone analogues as potential anticancer agents.
Sharma V; Kumar V; Kumar P
Anticancer Agents Med Chem; 2013 Mar; 13(3):422-32. PubMed ID: 22721390
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and topoisomerase II inhibitory and cytotoxic activity of oxiranylmethoxy- and thiiranylmethoxy-chalcone derivatives.
Na Y; Nam JM
Bioorg Med Chem Lett; 2011 Jan; 21(1):211-4. PubMed ID: 21115246
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the antineoplastic potential of chalcones in animal models.
Roman BI; Heugebaert TS; Bracke ME; Stevens CV
Curr Med Chem; 2013; 20(2):186-221. PubMed ID: 23244582
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel β-carboline based chalcones with high cytotoxic activity against breast cancer cells.
Chauhan SS; Singh AK; Meena S; Lohani M; Singh A; Arya RK; Cheruvu SH; Sarkar J; Gayen JR; Datta D; Chauhan PM
Bioorg Med Chem Lett; 2014 Jul; 24(13):2820-4. PubMed ID: 24844196
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, molecular modeling and biological evaluation of chalcone thiosemicarbazide derivatives as novel anticancer agents.
Zhang HJ; Qian Y; Zhu DD; Yang XG; Zhu HL
Eur J Med Chem; 2011 Sep; 46(9):4702-8. PubMed ID: 21816517
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and identification of α-cyano bis(indolyl)chalcones as novel anticancer agents.
Kumar D; Maruthi Kumar N; Tantak MP; Ogura M; Kusaka E; Ito T
Bioorg Med Chem Lett; 2014 Nov; 24(22):5170-4. PubMed ID: 25442306
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, and Evaluation of (2-(Pyridinyl)methylene)-1-tetralone Chalcones for Anticancer and Antimicrobial Activity.
Gibson MZ; Nguyen MA; Zingales SK
Med Chem; 2018; 14(4):333-343. PubMed ID: 29065840
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of C3-pyrazole/chalcone-linked beta-carboline hybrids: antitopoisomerase I, DNA-interactive, and apoptosis-inducing anticancer agents.
Kamal A; Srinivasulu V; Nayak VL; Sathish M; Shankaraiah N; Bagul C; Reddy NV; Rangaraj N; Nagesh N
ChemMedChem; 2014 Sep; 9(9):2084-98. PubMed ID: 24470122
[TBL] [Abstract][Full Text] [Related]
17. Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: synthesis and biological evaluation of antivascular activity.
Ducki S; Rennison D; Woo M; Kendall A; Chabert JF; McGown AT; Lawrence NJ
Bioorg Med Chem; 2009 Nov; 17(22):7698-710. PubMed ID: 19837593
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Cytotoxicity Evaluation, Molecular Docking and Utility of Novel Chalcones as Precursors for Heterocycles Incorporating Pyrazole Moiety.
Gomha SM; Abdallah MA; Abbas IM; Kazem MSH
Med Chem; 2018; 14(4):344-355. PubMed ID: 29065841
[TBL] [Abstract][Full Text] [Related]
19. Discovery of thiazole-based-chalcones and 4-hetarylthiazoles as potent anticancer agents: Synthesis, docking study and anticancer activity.
Farghaly TA; Masaret GS; Muhammad ZA; Harras MF
Bioorg Chem; 2020 May; 98():103761. PubMed ID: 32200332
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of methoxy-substituted chalcones and in vitro evaluation of their anticancer potential.
Ethiraj KR; Aranjani JM; Khan FR
Chem Biol Drug Des; 2013 Dec; 82(6):732-42. PubMed ID: 23834620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]